A hydrolysate of poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132) suppresses Cav3.2-dependent pain by sequestering exogenous and endogenous sulfide

This publication has 52 references indexed in Scilit:

• Involvement of the endogenous hydrogen sulfide/Ca_v3.2 T‐type Ca²⁺ channel pathway in cystitis‐related bladder pain in mice
  British Journal of Pharmacology, 2012
• Effects of a Lactobacilli, Oligosaccharide and Organic Germanium Intake on the Immune Responses of Mice
  Bioscience, Biotechnology, and Biochemistry, 2012
• ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis
  Pain, 2011
• T‐type voltage‐gated calcium channels as targets for the development of novel pain therapies
  British Journal of Pharmacology, 2011
• Hyperalgesia induced by spinal and peripheral hydrogen sulfide: Evidence for involvement of Cav3.2 T-type calcium channels
  Pain, 2009
• Hydrogen sulfide as a novel mediator for pancreatic pain in rodents
  Gut, 2009
• Hydrogen sulfide as a novel nociceptive messenger
  Pain, 2007
• Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice
  British Journal of Pharmacology, 2006
• 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells
  Cellular and Molecular Life Sciences, 1996
• Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57Bl/6 (B6) mice.
  The Tohoku Journal of Experimental Medicine, 1985